WO2007100376A3 - Compositions and methods for dermal delivery of drugs - Google Patents
Compositions and methods for dermal delivery of drugs Download PDFInfo
- Publication number
- WO2007100376A3 WO2007100376A3 PCT/US2006/048059 US2006048059W WO2007100376A3 WO 2007100376 A3 WO2007100376 A3 WO 2007100376A3 US 2006048059 W US2006048059 W US 2006048059W WO 2007100376 A3 WO2007100376 A3 WO 2007100376A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- volatile
- formulation
- methods
- volatile solvent
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200680052642XA CN101370453B (en) | 2005-12-14 | 2006-12-14 | Compositions and methods for dermal delivery of drugs |
JP2008545866A JP2009519956A (en) | 2005-12-14 | 2006-12-14 | Compositions and methods for skin delivery of drugs |
CA002633464A CA2633464A1 (en) | 2005-12-14 | 2006-12-14 | Compositions and methods for dermal delivery of drugs |
EP06849969A EP1968541A2 (en) | 2005-12-14 | 2006-12-14 | Compositions and methods for dermal delivery of drugs |
AU2006339350A AU2006339350A1 (en) | 2005-12-14 | 2006-12-14 | Compositions and methods for dermal delivery of drugs |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75052105P | 2005-12-14 | 2005-12-14 | |
US75063705P | 2005-12-14 | 2005-12-14 | |
US60/750,637 | 2005-12-14 | ||
US60/750,521 | 2005-12-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007100376A2 WO2007100376A2 (en) | 2007-09-07 |
WO2007100376A3 true WO2007100376A3 (en) | 2008-09-25 |
Family
ID=38459470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/048059 WO2007100376A2 (en) | 2005-12-14 | 2006-12-14 | Compositions and methods for dermal delivery of drugs |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1968541A2 (en) |
JP (1) | JP2009519956A (en) |
AU (1) | AU2006339350A1 (en) |
CA (1) | CA2633464A1 (en) |
WO (1) | WO2007100376A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2345414B1 (en) | 2008-10-08 | 2014-06-25 | Takata Seiyaku Co., Ltd. | Tacrolimus preparation for external applications |
US8809307B2 (en) | 2010-11-22 | 2014-08-19 | Dow Pharmaceutical Sciences, Inc. | Pharmaceutical formulations containing corticosteroids for topical administration |
US11957753B2 (en) | 2010-11-22 | 2024-04-16 | Bausch Health Ireland Limited | Pharmaceutical formulations containing corticosteroids for topical administration |
DE102011085509A1 (en) * | 2011-10-31 | 2013-05-02 | Beiersdorf Ag | Fixation of perfume on wet skin |
GB2496656B (en) * | 2011-11-18 | 2015-12-09 | Lrc Products | Film-Forming Formulation |
ES2745093T5 (en) * | 2013-11-14 | 2022-11-10 | Lipidor Ab | Sprayable topical carrier and composition comprising phosphatidylcholine |
US11090265B2 (en) | 2015-01-30 | 2021-08-17 | Medrx Co., Ltd. | Aqueous preparation for external use |
DK3310389T3 (en) | 2015-06-18 | 2020-08-10 | Bausch Health Ireland Ltd | TOPIC COMPOSITIONS INCLUDING A CORTICOSTEROID AND A RETINOID FOR THE TREATMENT OF PSORIASIS |
JP2022117477A (en) | 2021-01-29 | 2022-08-10 | 花王株式会社 | Composition for external application |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6653346B1 (en) * | 2002-02-07 | 2003-11-25 | Galileo Pharmaceuticals, Inc. | Cytoprotective benzofuran derivatives |
-
2006
- 2006-12-14 AU AU2006339350A patent/AU2006339350A1/en not_active Abandoned
- 2006-12-14 WO PCT/US2006/048059 patent/WO2007100376A2/en active Application Filing
- 2006-12-14 JP JP2008545866A patent/JP2009519956A/en not_active Withdrawn
- 2006-12-14 CA CA002633464A patent/CA2633464A1/en not_active Abandoned
- 2006-12-14 EP EP06849969A patent/EP1968541A2/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6653346B1 (en) * | 2002-02-07 | 2003-11-25 | Galileo Pharmaceuticals, Inc. | Cytoprotective benzofuran derivatives |
Also Published As
Publication number | Publication date |
---|---|
CA2633464A1 (en) | 2007-09-07 |
EP1968541A2 (en) | 2008-09-17 |
JP2009519956A (en) | 2009-05-21 |
WO2007100376A2 (en) | 2007-09-07 |
AU2006339350A1 (en) | 2007-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007070695A3 (en) | Flux-enabling compositions and methods for dermal delivery of drugs | |
WO2005120473A3 (en) | Dermal peel-forming formulation | |
WO2009017767A3 (en) | Compositions and methods for dermally treating neuropathy with minoxidil | |
WO2007100376A3 (en) | Compositions and methods for dermal delivery of drugs | |
WO2007070643A3 (en) | Compositions and methods for treating dermatological conditions | |
WO2007070679A3 (en) | Compositions and methods for dermally treating pain | |
WO2007070694A3 (en) | Spray-on formulations and methods for dermal delivery of drugs | |
WO2009085314A8 (en) | Compositions and methods for treating diseases of the nail | |
CN101677969B (en) | Matrix-type transdermal drug delivery system and preparation method thereof | |
WO2004089335A3 (en) | Non-aqueous single phase vehicles and formulations utilizing such vehicles | |
WO2006065991A3 (en) | Dispersion for delivering active agents | |
ECSP099635A (en) | LIQUID FORMULATIONS THAT FORM A DERMAL LAYER FOR THE RELEASE OF SKIN DRUGS | |
WO2007133508A8 (en) | Water dispersible films for delivery of active agents to the epidermis | |
WO2007078796A3 (en) | Topical administration carrier composition and therapeutic formulations comprising same | |
WO2006129161A3 (en) | Vitamin formulation | |
WO2005115336A3 (en) | Sprayable formulations for the treatment of acute inflammatory skin conditions | |
WO2007123955A3 (en) | Stable hydroalcoholic oral spray formulations and methods | |
WO2007133751A3 (en) | Base-stabilized polyorthoester formulations | |
WO2007103257A3 (en) | Method of powder coating medical devices | |
IN2014DN11232A (en) | ||
WO2010041141A3 (en) | Oil-based foamable carriers and formulations | |
BR0007997A (en) | Topical medical spray composition, dispenser containing a composition, preparation process for a dispenser, and use of a composition | |
WO2009100441A3 (en) | Depot formulations | |
WO2007100910A3 (en) | Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods | |
WO2005107710A3 (en) | Particles for the delivery of active agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2008545866 Country of ref document: JP Ref document number: 2633464 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006339350 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006849969 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1481/MUMNP/2008 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2006339350 Country of ref document: AU Date of ref document: 20061214 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200680052642.X Country of ref document: CN |